[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
Aug 2011

Anti–Vascular Endothelial Growth Factor Therapy and Renal Thrombotic MicroangiopathyAnti–VEGF Therapy and Renal Thrombotic Microangiopathy

Author Affiliations

Author Affiliations: Departments of Ophthalmology and Visual Sciences (Dr Sheibani) and Pediatrics (Dr Sorenson), and the University of Wisconsin Eye Research Institute (Drs Sheibani and Sorenson), University of Wisconsin School of Medicine and Public Health, Madison.

Author Affiliations: Departments of Ophthalmology and Visual Sciences (Dr Sheibani) and Pediatrics (Dr Sorenson), and the University of Wisconsin Eye Research Institute (Drs Sheibani and Sorenson), University of Wisconsin School of Medicine and Public Health, Madison.

Arch Ophthalmol. 2011;129(8):1082. doi:10.1001/archophthalmol.2011.199
×